Bertrand C. Liang
Director Técnico/Científico/I+D en PURPLE BIOTECH LTD .
Perfil
Bertrand C.
Liang was the founder of TRACON Pharmaceuticals, Inc. (founded in 2005) where he served as Chairman from 2005 to 2010, and Pfenex, Inc. (founded in 2009) where he held the position of President, CEO, Secretary & Class III Director from 2015 to 2017.
Dr. Liang is also the founder of Fortress Biotech, Inc. Dr. Liang's current jobs include Director at Asphelia Pharmaceuticals, Inc., Director at Balboa Biosciences, Inc., Managing Director & Executive Director at LCC Ventures (since 2014), Director at Pico Pharmaceuticals, Inc., and Chief Medical Officer at Purple Biotech Ltd.
(since 2020).
Dr. Liang's former jobs include Vice Chairman at Paramount BioCapital Asset Management, Inc., Vice Chairman at Paramount BioSciences LLC, Director at La Jolla Pharmaceutical Co. (2010-2012), Director at TRF Pharma, Inc., Global Development Leader at Amgen, Inc., Principal at Biogen MA, Inc., Vice President at Biogen, Inc., Vice President, Head-Hematology & Oncology at IDEC Corp., and Principal at The University of Colorado, the University of Vermont, and the National Cancer Institute.
Dr. Liang's education includes an undergraduate degree from Boston University, an MBA from Regis University, a doctorate from The University of Bolton, and a doctorate from Feinberg School of Medicine.
Dr. Liang is also the founder of Fortress Biotech, Inc...
Cargos activos de Bertrand C. Liang
| Empresas | Cargo | Inicio |
|---|---|---|
| PURPLE BIOTECH LTD | Director Técnico/Científico/I+D | 09/01/2020 |
| Pico Pharmaceuticals, Inc. | Director/Miembro de la Junta | 08/12/2009 |
| Asphelia Pharmaceuticals, Inc. | Director/Miembro de la Junta | 08/12/2009 |
| LCC Ventures | Director/Miembro de la Junta | 08/12/2009 |
Balboa Biosciences, Inc.
 Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Bertrand C. Liang.
| Empresas | Cargo | Fin |
|---|---|---|
| PFENEX INC. | Fundador | 23/01/2017 |
| LA JOLLA PHARMACEUTICAL COMPANY | Director/Miembro de la Junta | 19/01/2012 |
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Gestor de Cartera-Acciones | 30/04/2007 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Director/Miembro de la Junta | - |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Bertrand C. Liang.
| Regis University | Masters Business Admin |
| The University of Bolton | Doctorate Degree |
| Boston University | Undergraduate Degree |
| Feinberg School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| IDEC CORPORATION | Electronic Technology |
| BIOGEN INC. | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| PURPLE BIOTECH LTD | Health Technology |
| Empresas privadas | 11 |
|---|---|
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
TRF Pharma, Inc.
 TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Health Technology |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Health Technology |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Paramount BioCapital Asset Management, Inc.
Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
| LCC Ventures | |
| Asphelia Pharmaceuticals, Inc. | |
| Pico Pharmaceuticals, Inc. | |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Bertrand C. Liang